Evidence map›Paper›PMID 42450021›Full record

ArticleInternational journal of molecular sciences2026

Hye-Yeon Kang, Bong-Keun Jang, Seong-Hoon Yun, Hee-Yeong Jeong, Eunkuk Park, Kang-Il Oh, Junhwan Jeong, Seon-Yong Jeong

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hye-Yeon KangJBKLAB, Inc., 17 Techno 4-ro, Yuseoung-gu, Daejeon 34013, Republic of Korea.
Bong-Keun JangJBKLAB, Inc., 17 Techno 4-ro, Yuseoung-gu, Daejeon 34013, Republic of Korea.
Seong-Hoon YunJBKLAB, Inc., 17 Techno 4-ro, Yuseoung-gu, Daejeon 34013, Republic of Korea.ORCID 0000-0002-6197-1383
Hee-Yeong JeongJBKLAB, Inc., 17 Techno 4-ro, Yuseoung-gu, Daejeon 34013, Republic of Korea.
Eunkuk ParkDepartment of Medical Genetics, Ajou University School of Medicine, Suwon 16499, Republic of Korea.ORCID 0000-0002-1928-5531
Kang-Il OhDepartment of Medical Genetics, Ajou University School of Medicine, Suwon 16499, Republic of Korea.ORCID 0000-0001-7787-7394
Junhwan JeongDepartment of Medical Genetics, Ajou University School of Medicine, Suwon 16499, Republic of Korea.ORCID 0009-0008-5871-2656
Seon-Yong JeongDepartment of Medical Genetics, Ajou University School of Medicine, Suwon 16499, Republic of Korea.ORCID 0000-0002-0625-3530

Funding

Ministry of Health and Welfare RS-2021-KH113820Ministry of Health and Welfare RS-2022-KH130303Ministry of Health and Welfare RS-2025-25303051
6 · The paper itself

Abstract

Preventing or reversing Tau hyperphosphorylation and aggregation represent critical objectives in the development of effective therapies for Alzheimer's disease. The present study investigated the potential of a novel

Indexed as

Alginic AcidAlzheimer DiseasePlant Extractstau ProteinsCell Line, TumorGlycogen Synthase Kinase 3 betaHEK293 CellsHumansPhosphorylationProtein AggregatesProto-Oncogene Proteins c-aktAlginic AcidGlycogen Synthase Kinase 3 betaPlant ExtractsProtein AggregatesProto-Oncogene Proteins c-akttau ProteinsAlzheimer’s diseaseAronia bioactive fraction-alginic acid nanocomplex (AANCP)Aronia melanocarpaautophagyglycogen synthase kinase-3βTau aggregationtauopathyTau phosphorylation

Identifiers

PMID42450021
PMCPMC13361874

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.